| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 The School of Exercise and Sport Science, The University of Sydney, Australia 2 Institute of Food, Nutrition and Human Health, Massey University, New Zealand 3 General Medicine, Flinders Medical Centre, Flinders University, Australia 4 Rayscan Imaging, 40–46 Goulburn Street, Liverpool, Australia
 |
Abstract |
|---|
 Top Abstract IntroductionMethodsResultsDiscussionReferences |
|---|
(Received 31 January 2006;
accepted after revision 10 April 2006; first published online 20 April 2006)
Corresponding author N. A. Johnson: School of Exercise and Sport Science, The University of Sydney, Lidcombe 1825, Australia. Email: n.johnson{at}fhs.usyd.edu.au
|
Introduction |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
In vitro research has confirmed a causative relationship between fat excess and muscle fibre insulin resistance by demonstrating that fat-induced accumulation of IMTG and related intramyocellular lipid moieties interferes with normal intracellular insulin signalling in skeletal muscle (Schmitz-Peiffer et al. 1999; Ellis et al. 2000; Boden et al. 2001; Itani et al. 2002), leading to impaired cellular glucose transport/phosphorylation (Roden et al. 1996).
However, whilst insulin resistance may be caused by fat accumulation at a cellular level, it is not exclusively a function of dietary fat intake in the intact human. For example, in lean, healthy individuals, short-term starvation reduces whole-body and muscle insulin sensitivity (Mansell & Macdonald, 1990; Webber et al. 1994). Starvation also elevates IMTG (Stannard et al. 2002), which is largely a function of the increased circulating free fatty acid (FFA) concentration associated with energy restriction (Cahill et al. 1966; Klein et al. 1993). Thus, a high-fat diet and starvation are similar in that they both result in IMTG accumulation and concurrent whole-body insulin resistance, despite the fact that they differ vastly in dietary fat and energy intake. Investigation is therefore required to ascertain the overarching role of diet in IMTG kinetics and insulin sensitivity in human physiology.
The unifying characteristic between all experimental reports of starvation- or high-fat diet-induced insulin resistance and/or glucose intolerance in healthy individuals is that both diets involve carbohydrate (CHO) restriction.
Adipose lipolysis, plasma free fatty acids (FFAs) and whole-body fat metabolism are elevated within hours of initiating a restricted CHO diet, and these adaptations are a direct function of CHO restriction rather than fat intake or total energy deficiency (Klein & Wolfe, 1992; Schwarz et al. 1995). This implies that the current lipocentric interpretation of dietary-induced IMTG accumulation and insulin resistance (Bachmann et al. 2001; Decombaz et al. 2001; Greco et al. 2002; Larson-Meyer et al. 2002) may be misleading.
We contend that in lean, healthy individuals, dietary CHO restriction independently mediates IMTG accumulation and insulin resistance. It seems teleologically sensible that insulin resistance and IMTG accumulation should occur as a co-ordinated (non-pathological) physiological response to CHO restriction. This is because the central nervous system (CNS), being obligate for CHO and not requiring insulin for glucose uptake, has priority over muscle for residual circulating glucose. Yet, at the same time, preservation of a non-CHO intramuscular substrate is necessary for physical ability, and elevation of IMTG content fulfils this role (Stannard & Johnson, 2004).
However, to date no investigation has compared, within the same subject group, the effect of CHO restriction independent of energy and fat intake on insulin sensitivity and IMTG kinetics.
In this study we exposed lean, physically fit men to two 
3 day dietary treatments, namely low-CHO/high-fat and starvation, which had in common significant restriction of CHO intake. We hypothesized that these diets would induce equivalent levels of IMTG accumulation and reductions of insulin sensitivity despite large differences in fat intake and energy content. All results were compared with those observed after the same period of a normal mixed diet.
|
Methods |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Seven healthy, physically fit males volunteered for this study (age, 30.0 ± 6.0 years; weight, 72.8 ± 5.9 kg). All subjects reported regularly undertaking exercise for more than 1.5 h daily, at least 5 days per week. Participants were informed of the study protocol and risks before providing their written consent. The study was approved by the Human Research Ethics Committee of The University of Sydney and conformed with the Declaration of Helsinki.
Preliminary testing
One week prior to participation in the dietary intervention phases of the study, maximal oxygen uptake 
during cycling exercise was determined for each participant via electronically braked cycle ergometer (Schoberer Radmesstechnik, Konigskamp, Germany). The test required the subject to cycle at four submaximal steady-state power outputs, followed by an incremental increase in power (45 W min–1) until volitional fatigue. Oxygen consumption 
was measured by the Douglas bag method and expired gas was collected for no less than 40 s immediately prior to fatigue for determination of 
. External power output and 
attained during the final 2 min of each submaximal workload and the maximal ramp were used to formulate regression equations from which workloads for the control exercise bout were derived.
Resting metabolic rate (RMR) was determined within 1 week of initiation of the first diet manipulation. Subjects presented for assessment following a 12 h overnight fast. After resting supine for 30 min, respiratory gases were collected through a face-mask connected to a two-way rebreathable valve and Douglas bag. Expired respiratory gas was collected for 15 min, and mean 
calculated. Oxygen and CO2 fractions of expired air were measured using zirconium cell-based O2 and CO2 sensors (Pm111E; Ir1507, Servomex, Crowborough, UK). Both analysers were calibrated immediately before each test using gases of known composition. Pulmonary ventilation volume was measured by automated volume meter (Harvard, Edenbridge, UK). Body density was assessed via hydrodensitometry, and percentage body fat then calculated using a two-compartment model, as described by Brozek et al. (1963). The best of three measurements is reported. Underwater body weight measurements were corrected for estimated residual lung volume (Goldman & Becklake, 1959).
Experimental protocol
All subjects underwent three dietary interventions, separated by at least 7 days. Each diet period was of 67 h duration and comprised: (a) water-only starvation (S); (b) very low-CHO/high-fat intake (LC); or (c) mixed CHO control diet (C). These extreme diets were selected because they allowed the physiological responses to a normal versus low CHO intake to be examined (C versus LC and S), whilst controlling for protein (C and LC), fat (S and LC) and energy intakes (LC and C). The order in which dietary interventions were administered was randomized. Participants were supervised during all dietary interventions.
As a standardized preconditioning measure prior to the initiation of the treatments, participants ingested a mixed meal that provided 1.5 g CHO (kg body weight)–1 with a macronutrient contribution of 50, 35 and 15% as CHO, fat and protein, respectively. Four hours after this meal, participants performed a 60 min bout of laboratory-based cycling exercise at a workload calculated to elicit 65% of 
. This exercise (performed at the same power output for each individual prior to all experimental treatments), in combination with the control meal, was designed to standardize endogenous substrate availability prior to the dietary manipulation in addition to controlling for effects of exercise on subsequent insulin sensitivity and glucose tolerance. For further standardization, subjects were also required to record their exercise training and diet during the 24 h preceding the control exercise bout, and the same exercise and diet regime was followed prior to all dietary interventions.
Upon completion of exercise, subjects ingested a snack high or low in CHO content, according to their allocation to the C or LC condition, respectively. This liquid meal provided 1 g CHO (kg body weight)–1 (100% energy as CHO) in C or an isocaloric meal comprising 1% energy as CHO, 98% as fat and 1% as protein in the LC treatment. Subjects ingested an evening meal 2 h later prior to sleep. This meal comprised 1.5 g CHO (kg body weight)–1 as 50% CHO, 35% fat and 15% of energy as protein in C and an isocaloric meal with 2% CHO, 83% fat and 15% of energy as protein in the LC treatment. Beginning the following morning and continuing for the remainder of the dietary treatment (48 h), subjects received diets in both C and LC which provided energy to match a daily expenditure of 1.5 x RMR. This equated with the recommendations of the National Health and Medical Research Council (NHMRC) for resting energy requirement and light daily activity in young males (NHMRC, 2003). Isocaloric provision of energy was intended to deliver 50% of energy as CHO, 35% as fat and 15% as protein in C and negligible CHO; 85% fat and 15% of energy as protein in LC. Thus, both the control (C) condition and LC dietary treatment were designed to provide enough energy to sustain metabolic requirement for rest and light activity, to be equal in protein and to differ only in CHO and fat content. After exercise in the S treatment, participants continued a water-only diet until completion of the experimental treatment. Diet composition was quantified via Foodworks (Xyris Software®, Melbourne, Australia). In all dietary interventions, subjects were instructed to maintain activities of daily living and avoid all forms of recreational exercise.
Determination of IMTG content
After 65 h of each diet, vastus lateralis IMTG content was measured via proton magnetic resonance spectroscopy (1H-MRS). As is customary for 1H-MRS, IMTG content was determined by the methylene (—(CH2)n) resonance from intramyocellular lipid (IMCL) at 1.3 p.p.m. referenced to intracellular water (Szczepaniak et al. 1999). High-resolution T1-weighted imaging and image-guided, localized 1H-MRS were performed on a 1.5 Tesla Gyroscan NT whole-body system (Philips Medical Systems; Best, The Netherlands) using a combination of whole-body and circular polarized standard extremity coils for radio frequency signal transmission and reception. Volumes of interest were centred within the vastus lateralis muscle at the level of mid-femur. Legs were fixed with the thigh orientated so that the muscle fibres of the vastus lateralis were aligned with the magnetic field of the body coil. A vitamin E capsule was taped to the skin to identify the area of interest on the MR images. Image-guided spectra were acquired using the PRESS technique (repition time [TR] = 5000 ms, spin echo time [TE] = 32 ms, 32 measurements, 1024 sample points; acquisition time, 3 min). Fully automated shimming was performed on a 5 cm x 1.5 cm x 1.5 cm voxel to ensure maximum field homogeneity. Excitation water suppression was used to suppress the water signal during data acquisition. Unsuppressed water spectra were acquired for use as an internal standard. Spectral data were processed with magnetic resonance user interface software (jMRUI version 1.1, EU Project ‘Advanced Signal Processing for Medical Magnetic Resonance Imaging and Spectroscopy’, TMR, FMRX-CT97-0160; Naressi et al. 2001) according to the constraints previously described (Johnson et al. 2003). Absolute IMTG content was also calculated in mmol (kg wet weight [w.w.])–1 using the internal reference of muscle water concentration by assuming a water concentration of 55 mmol (kg w.w.)–1, a tissue water fraction of 0.81 and density of 1.05 (Szczepaniak et al. 1999) and assuming an IMCL structure similar to trioleate (61.0 mmol of 1H (ml triglyceride)–1).
Intravenous glucose tolerance test
Following determination of IMTG content, subjects reported to the laboratory where glucose tolerance was assessed by frequently sampled intravenous glucose tolerance test (IVGTT). Intravenous rather than oral glucose tolerance test (OGTT) was chosen in order to avoid potential confounding effects of diet (including starvation; Corvilain et al. 1995) on gastric emptying (Horowitz et al. 1993) and subsequent glucose tolerance. Intravenous glucose tolerance test was undertaken after a 12 h overnight fast (C and LC; 67 h of dietary intervention). Venous cannulae were inserted into the antecubital veins of each arm. One cannula was used for glucose infusion and the other for venous blood collection. Basal blood samples were collected after 15 min at rest, following which the IVGTT was initiated. Participants rested in a supine position throughout the IVGTT. The subject was infused with 0.3 g kg–1 of glucose (50% anhydrous glucose with sodium bicarbonate or hydrochloric acid for pH adjustment; AstraZeneca, Sydney, Australia) via syringe evenly over 2 min. Glucose infusion was immediately followed by infusion of 10 ml of saline. Venous blood was sampled for determination of plasma glucose and insulin concentrations from the indwelling cannula in the contralateral arm at 3, 4, 5, 6, 7, 8, 10, 14, 19, 22, 25, 30, 40, 60, 70, 80, 100, 140 and 180 min after the initiation of glucose infusion (Pacini & Bergman, 1986). All samples were collected within 15 s. Additional blood samples were collected at 15, 30, 60 and 120 min for determination of plasma FFA concentrations. Throughout the experiment, cannulae were kept patent by periodic flushing with saline.
Blood sampling
Prior to the IVGTT, 3 ml of venous blood was sampled by syringe, 0.75 ml of which was added to 1.5 ml of 0.6 M perchloric acid for later determination of blood ß-hydroxybutyrate (ß-OH) concentration. The remainder was transferred into EDTA, placed on ice and then centrifuged at 2000 g within 30 min of collection. The plasma was stored at –85°C and later analysed for FFA concentration. An additional 2 ml of venous blood was withdrawn into a lithium heparin-pelleted syringe. This sample was mixed and rested on ice for 5 min, after which 1.3 ml was transferred into blood tubes, centrifuged at 2000 g, and the plasma frozen (–85°C) for later determination of plasma insulin concentration. Residual blood remained on ice in the lithium heparin-pelleted syringe for later determination of plasma glucose concentration. Blood for glucose, insulin and FFA measurement was sampled according to these methods during the ensuing IVGTT (1 ml for EDTA) according to the sampling schedule outlined above.
Analytical procedures and calculations
Plasma glucose concentration was measured by autoanalyser (EML, Copenhagen, Denmark). The plasma concentration of FFAs was determined using a Wako NEFA C Test kit (WAKO Chemical, Richmond, VA, USA) scaled for use in a microplate (Bio-Rad, Hercules, CA, USA). The method of Ruell & Gass (1991) was used for the spectrophotometric determination of blood ß-OH concentration. All measurements were made in duplicate and the mean reported. Plasma insulin concentration was determined by microplate enzyme immunoassay (MEIA) using a fully automated procedure (AxSYM®, Abbot Laboratories, Sydney, Australia).
Glucose tolerance was determined by the rate of decline in plasma glucose concentration between 10 and 40 min of IVGTT (Kg) as outlined by Galvin et al. (1992) where:
|
|
Indices of estimated whole-body insulin sensitivity were also obtained via: (a) the ratio of the AUC for plasma glucose to insulin (SIAUC; Horowitz et al. 2005); (b) the method proposed by Galvin and coworkers which correlates highly (r
= 0.85) with insulin sensitivity measured via hyperinsulinaemic–euglycaemic clamp (Galvin et al. 1992):
|
|
|
|
Statistics
Differences in nutritional intake were compared by Student's paired t test. All basal measures (plasma glucose, insulin, FFA, blood ß-OH and IMCL:water) and differences in indices of glucose tolerance, insulin sensitivity and Sg between conditions were compared by one-way repeated measures ANOVA. Plasma glucose, insulin and FFA concentrations during IVGTT were compared by two-way repeated measures ANOVA for investigation of treatment and time (diet–time) interactions. Pearson correlation coefficients (two-tailed) were used to express the relationship between IMCL:water and Si and in IMCL:water content between dietary conditions. Statistical significance was accepted at P < 0.05. Calculations were performed using SPSS for Windows version 11. All values are expressed as means ± S.D.
|
Results |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
|
Carbohydrate intake in LC was significantly lower than in C (P < 0.01), the diets providing 13.9 ± 0.9 and 392.0 ± 31.5 g kg–1 day–1, respectively. Dietary fat intake was significantly higher in LC versus C (P < 0.01; Table 2). Daily energy and protein intakes were not different between LC and C (P > 0.05). Despite our efforts to abolish its intake, CHO consumption in LC was higher than that during S (P < 0.01; Table 2).
|
Owing to limited availability of the 1H-MRS, the period of dietary intervention was extended from 67 to 69 h for one subject. All other interventions for this individual were adjusted to 69 h, accordingly. The ratio of vastus lateralis IMCL:water was significantly higher in LC (13.6 ± 3.5 x 10–3) and S (13.0 ± 2.4 x 10–3) when compared with C (7.3 ± 3.2 x 10–3; P < 0.01 for both). The ration of IMCL:water was not different between LC and S (P = 0.46; Fig. 1). Calculated absolute IMTG content was 12.9 ± 5.3, 23.8 ± 6.0 and 22.6 ± 4.1 mmol (kg w.w.)–1 in C, LC and S, respectively. Intramyocellular triglyceride content in the treatment conditions demonstrated a high within-subject correlation with that measured in C (r = 0.94, LC versus C; r = 0.92, S versus C, P < 0.01 for both).
|
Following dietary intervention, the basal plasma glucose concentration was lower in S versus C (P < 0.01) but was not different between LC and C (P = 0.13). The basal plasma glucose concentration tended to be lower after S versus LC (P = 0.06; Table 3). The basal plasma insulin concentration was significantly lower in S versus C (P < 0.01) and in LC versus C (P < 0.05). The basal plasma insulin concentration tended towards being lower after S versus LC (P = 0.08; Table 3). The basal plasma FFA and blood ß-OH concentrations were higher in S versus C (P = 0.01) and in LC versus C (P < 0.01). Free fatty acids and ß-OH concentrations were higher in S versus LC (P = 0.01; Table 3).
|
In all dietary interventions, the plasma glucose concentration increased rapidly following intravenous glucose infusion, reaching a peak 5–10 min thereafter. Glucose concentration declined after this time and was not different between conditions by 140 min (Fig. 2A). There was a significant diet–time interaction for the plasma glucose response to IVGTT (P
= 0.01). While no difference in glucose concentration was evident between dietary interventions 3–8 min after glucose infusion, plasma glucose concentration was significantly higher after this time in LC and S compared with C (Fig. 2A). There was no difference in plasma glucose response to glucose infusion between LC and S (Fig. 2A). For three data points, the plasma insulin concentration was lower than the limit detectable by the assay (< 6 pmol l–1). A value of 5 pmol l–1 was assumed for these instances. In addition, one sample was haemolysed, so the value was subsequently fitted to the curve from a polynomial (concentration versus time) fitted to the rest of the individuals insulin data. In all dietary interventions, the plasma insulin concentration increased rapidly following intravenous glucose infusion, reaching a peak between 4 and 8 min. Thereafter, insulin concentration declined and was similar to basal levels after 140 min in all dietary treatments (Fig. 2B). There was no significant effect of diet on the plasma insulin response to glucose infusion (Fig. 2B). Plasma FFAs are expressed for five subjects during IVGTT because multiple samples were haemolysed in one individual and insufficient blood was available from another. There was a significant difference in the plasma FFA concentration between dietary interventions during the IVGTT (P < 0.01). Free fatty acids declined following glucose infusion, reaching a nadir at 60 min. There was a significant difference in the FFA response to glucose infusion between diets (P < 0.05), with the decline in plasma FFAs following glucose infusion being more pronounced in S versus C between 0 and 30 min of the IVGTT (Fig. 2C).
|
Insulin sensitivity index (Si) measured via the Minimal Model was significantly impaired in S when compared with C (P < 0.05). There was a tendency for insulin sensitivity to be impaired in LC versus C although this did not reach statistical significance (P = 0.08). There was no difference in insulin sensitivity index (Si) between LC and S (P = 0.27; Table 4). There was no effect for diet on Sg (P = 0.55; Table 4).
|
Glucose tolerance as measured by Kg was impaired in LC (P < 0.05) and S (P < 0.01). No difference in Kg was evident between LC and S (P = 0.29; Table 4). When compared with C, mean AUC for glucose was 83 and 122% higher in LC and S, respectively (P < 0.01 for both; Table 4). The AUC for plasma glucose was also significantly higher in S compared with LC (P < 0.01).
Compared with C, ‘insulin sensitivity’ assessed by SIAUC was higher in LC and S (P < 0.01 for both), indicating reduced insulin sensitivity in these treatments. SIGalvin and the ISI values indicated reduced insulin sensitivity in S (P < 0.01 for both) but did not reach statistical significance between LC and C (P = 0.08–0.09). No difference in insulin sensitivity was evident between S and LC as determined by SIGalvin (P = 0.32), but SIAUC and ISI indices demonstrated lower insulin sensitivity in S versus LC (P < 0.05 for both; Table 4).
|
Discussion |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Therefore, while our present findings concur with a notion of ‘lipid-induced insulin resistance’ (Roden et al. 1996), IMTG accumulation and the development of insulin resistance following starvation are normal physiological responses mediated by an increase in adipose-derived plasma FFAs. Whilst it is possible that the equivalent level of IMTG accumulation and insulin resistance observed after LC in the present study may have occurred by chance consequent to fat ingestion, we interpret this outcome as indicating that these diabetogenic perturbations are mediated by a common factor following starvation and low-CHO/high-fat diets, namely dietary CHO restriction. In contrast to CHO, fat intake has previously been shown to exert no effect on adipose lipolysis, whole-body substrate selection or plasma FFA and insulin concentrations (Klein & Wolfe, 1992; Schwarz et al. 1995). Thus, we suggest that dietary-induced IMTG accumulation and insulin resistance in healthy humans may be largely influenced by circulating FFAs, whose availability (in turn) is regulated by dietary CHO intake.
However, from the present data we cannot conclude that IMTG accumulation, glucose intolerance and insulin resistance were mediated exclusively by dietary CHO restriction and its effects on FFA availability. In other words, we cannot exclude a possible contribution of ‘non-FFA’ lipid sources, such as plasma triglycerides (TAGs) and food-derived chylomicrons to IMTG accumulation and insulin resistance (in LC). For example, whilst cessation of food-derived chylomicron appearance and unchanged plasma triglyceride concentrations during starvation (Stannard et al. 2002) suggest that these metabolic alterations are solely a consequence of circulating FFA uptake and esterification, identification of any contribution from dietary lipids to IMTG formation and insulin resistance in LC would require isotope labelling of ingested lipid. Furthermore, an assumption of this study was that the low-CHO/high-fat diet (LC) employed would exert a physiological effect consistent with that observed following nil CHO ingestion. However, removing all the dietary CHO in the LC treatment was not possible if the diet was to contain the same energy and protein content as the control (C) treatment. Whilst both CHO-restricted treatments significantly lowered basal plasma insulin and elevated FFA concentrations (Table 3), these outcomes were slightly but significantly augmented in S versus LC, possibly owing to the residual quantity of dietary CHO (and/or protein) ingested in the low-CHO/high-fat (LC) treatment. Despite this, insulin sensitivity and IMTG content were similar between S and LC conditions. Lastly, owing to the duration, macronutrient mix and energy content employed in the treatments, our results do not describe the time course of these metabolic responses and do not infer that CHO influences these diabetogenic alterations across a wide range of energy/fat intakes. We measured IMTG content and insulin sensitivity after 67 h of diet manipulation to equate with other literature reports of IMTG accumulation (Bachmann et al. 2001; Stannard et al. 2002) and insulin resistance (Webber et al. 1994; Bachmann et al. 2001) following starvation or high-fat diets. It is likely that short-term consumption of excess energy/fat intake may precipitate further IMTG formation (Fox et al. 2004) and possibly augment insulin resistance, although Fox et al. (2004) failed to demonstrate the latter after 24 h of excess fat consumption in healthy individuals.
Taken together, these findings provide support for our hypothesis that short-term restriction of CHO intake independently influences IMTG accumulation and insulin resistance, at least under ‘normal’ dietary conditions, excluding those which promote weight gain and obesity. However, due to the design of the present study, we cannot exclude some role for dietary fat in these metabolic responses.
Owing to the difficulty in assessing insulin sensitivity from the variable plasma glucose and insulin concentrations observed during glucose tolerance tests, we employed several methods purported to evaluate the effect of insulin on circulating glucose disposal. In both healthy individuals and those with type 2 diabetes, Minimal Model-derived insulin sensitivity (Si) correlates highly (r = 0.8–0.9) with that determined by the hyperinsulinaemic–euglycaemic clamp (Bergman et al. 1987; Saad et al. 1994; Anderson et al. 1995). Our Si values are similar to those reported in two recent investigations using IVGTT and Minimal Model analysis in physically fit individuals (Goedecke et al. 2001; Schenk et al. 2005). The finding of similar Minimal Model-derived insulin resistance between LC and S is intuitive given the marked glucose intolerance observed in these conditions yet similarity of the dynamic plasma insulin and glucose responses to glucose infusion between these treatments (Fig. 2). That a similar reduction of ‘insulin sensitivity’ between LC and S treatments was not confirmed by the ISI index (Matsuda & DeFronzo, 1999) or by the ratio of the area under the curve (AUC) for glucose:insulin (Table 4) is likely to be a reflection of differences in basal glucose and insulin concentrations between LC and S rather than differences in the dynamic glucose–insulin interaction.
In this investigation we observed a significant negative correlation (r = –0.63, P < 0.01) between IMTG concentration and Minimal Model insulin sensitivity (Si) after 65–67 h of dietary manipulation (Fig. 3). This supports an increasing volume of evidence which links the excessive availability of circulating lipids (Roden et al. 1996; Bachmann et al. 2001), IMTG (Krssak et al. 1999; Goodpaster et al. 2001) and related intramyocellular fatty acid moieties (Schmitz-Peiffer et al. 1999; Ellis et al. 2000; Boden et al. 2001; Itani et al. 2002) to impairment of insulin-mediated blood glucose disposal. While confirming other reports of lipid-induced IMTG accumulation in response to high-fat diets (Bachmann et al. 2001) and artificial lipid infusion (Bachmann et al. 2001; Boden et al. 2001), our study provides support for the hypothesis that the physiological trigger for this coupling in the healthy individual may be a short-term challenge to dietary CHO availability. That we have observed these diabetogenic alterations in a physically fit population, which is purported to be insulin sensitive yet exhibits high IMTG concentrations (the ‘athlete paradox’) (Goodpaster et al. 2001), supports our contention that they represent an adaptive rather than pathological response. This substantiates our previous assertion that alterations in glucose tolerance and insulin sensitivity associated with dynamic changes to the plasma and/or lean tissue lipid profile are part of a normal co-ordinated adaptation to short-term changes in food availability (Stannard & Johnson, 2004) and perhaps, more specifically, to fluctuations of dietary CHO availability.
|
In conclusion, this investigation demonstrated that in the same lean, physically fit men, dietary-induced elevation of intramyocellular triglyceride and impairment of glucose tolerance/insulin sensitivity were similar after 67 h of low-CHO/high-fat diet and the same period of starvation. These findings may indicate that short-term dietary-induced IMTG accumulation and the concurrent development of insulin resistance in physically fit men are mediated largely by dietary CHO restriction rather than fat intake.
|
References |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Bachmann
OP, Dahl
DB, Brechtel
K, Machann
J, Haap
M, Maier
T, Loviscach
M, Stumvoll
M, Claussen
CD, Schick
F, Haring
HU
&
Jacob
S (2001). Effects of intravenous and dietary lipid challenge on intramyocellular lipid content and the relation with insulin sensitivity in humans. Diabetes
50, 2579–2584.
Bergman RN, Prager R, Volund A & Olefsky JM (1987). Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. J Clin Invest 79, 790–800.[Medline]
Boden
G, Lebed
B, Schatz
M, Homko
C
&
Lemieux
S (2001). Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects. Diabetes
50, 1612–1617.
Brozek J, Grande F, Anderson JT & Keys A (1963). Densiometric analysis of body composition: revision of some quantitative assumptions. Ann N Y Acad Sci 110, 113–140.[Medline]
Bruce
CR, Anderson
MJ, Carey
AL, Newman
DG, Bonen
A, Kriketos
AD, Cooney
GJ
&
Hawley
JA (2003). Muscle oxidative capacity is a better predictor of insulin sensitivity than lipid status. J Clin Endocrinol Metab
88, 5444–5451.
Cahill GF, Herrera MG, Morgan AP, Soeldner JS, Steinke J, Levy PL, Reichard GA & Kipnis DM (1966). Hormone-fuel interrelationships during fasting. J Clin Invest 45, 1751–1769.[Medline]
Corvilain B, Abramowicz M, Fery F, Schoutens A, Verlinden M, Balasse E & Horowitz M (1995). Effect of short-term starvation on gastric emptying in humans: relationship to oral glucose tolerance. Am J Physiol 269, G512–G517.
Decombaz
J, Schmitt
B, Ith
M, Decarli
B, Diem
P, Kreis
R, Hoppeler
H
&
Boesch
C (2001). Postexercise fat intake repletes intramyocellular lipids but no faster in trained than in sedentary subjects. Am J Physiol Regul Integr Comp Physiol
281, R760–R769.
Ellis
BA, Poynten
A, Lowy
AJ, Furler
SM, Chisholm
DJ, Kraegen
EW
&
Cooney
GJ (2000). Long-chain acyl-CoA esters as indicators of lipid metabolism and insulin sensitivity in rat and human muscle. Am J Physiol Endocrinol Metab
279, E554–E560.
Fox
AK, Kaufman
AE
&
Horowitz
JF (2004). Adding fat calories to meals after exercise does not alter glucose tolerance. J Appl Physiol
97, 11–16.
Fryburg DA, Barrett EJ, Louard RJ & Gelfand RA (1990). Effect of starvation on human muscle protein metabolism and its response to insulin. Am J Physiol 259, E477–E482.
Galvin P, Ward G, Walters J, Pestell R, Koschmann M, Vaag A, Martin I, Best JD & Alford F (1992). A simple method for quantitation of insulin sensitivity and insulin release from an intravenous glucose tolerance test. Diabet Med 9, 921–928.[Medline]
Goedecke JH, Levitt NS, St Clair Gibson A, Grobler L, Noakes TD & Lambert EV (2001). Insulin sensitivity measured by the minimal model: no associations with fasting respiratory exchange ratio in trained athletes. Metabolism 50, 1286–1293.[Medline]
Goldman HI & Becklake MR (1959). Respiratory function tests: normal values at medium altitudes and the prediction of normal results. Am Rev Respir Dis 79, 457–467.
Goodpaster
BH, He
J, Watkins
S
&
Kelley
DE (2001). Skeletal muscle lipid content and insulin resistance: evidence for a paradox in endurance-trained athletes. J Clin Endocrinol Metab
86, 5755–5761.
Greco
AV, Mingrone
G, Giancaterini
A, Manco
M, Morroni
M, Cinti
S, Granzotto
M, Vettor
R, Camastra
S
&
Ferrannini
E (2002). Insulin resistance in morbid obesity: reversal with intramyocellular fat depletion. Diabetes
51, 144–151.
Horowitz M, Edelbroek MA, Wishart JM & Straathof JW (1993). Relationship between oral glucose tolerance and gastric emptying in normal healthy subjects. Diabetologia 36, 857–862.[CrossRef][Medline]
Horowitz
JF, Kaufman
AE, Fox
AK
&
Harber
MP (2005). Energy deficit without reducing dietary carbohydrate alters resting carbohydrate oxidation and fatty acid availability. J Appl Physiol
98, 1612–1618.
Itani
SI, Ruderman
NB, Schmieder
F
&
Boden
G (2002). Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C and I
B-
. Diabetes
51, 2005–2011.
Johnson
NA, Stannard
SR, Mehalski
K, Trenell
MI, Sachinwalla
T, Thompson
CH
&
Thompson
MW (2003). Intramyocellular triacylglycerol in prolonged cycling with high- and low-carbohydrate availability. J Appl Physiol
94, 1365–1372.
Kather H, Bieger W, Michel G, Aktories K & Jakobs KH (1985). Human fat cell lipolysis is primarily regulated by inhibitory modulators acting through distinct mechanisms. J Clin Invest 76, 1559–1565.[Medline]
Klein S, Sakurai Y, Romijn JA & Carroll RM (1993). Progressive alterations in lipid and glucose metabolism during short-term fasting in young adult men. Am J Physiol 265, E801–E806.[Medline]
Klein S & Wolfe RR (1992). Carbohydrate restriction regulates the adaptive response to fasting. Am J Physiol 262, E631–E636.
Krssak M, Falk Petersen K, Dresner A, DiPietro L, Vogel SM, Rothman DL, Roden M & Shulman GI (1999). Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study. Diabetologia 42, 113–116.[CrossRef][Medline]
Larson-Meyer
DE, Newcomer
BR
&
Hunter
GR (2002). Influence of endurance running and recovery diet on intramyocellular lipid content in women: a 1H NMR study. Am J Physiol Endocrinol Metab
282, E95–E106.
Mansell PI & Macdonald IA (1990). The effect of starvation on insulin-induced glucose disposal and thermogenesis in humans. Metabolism 39, 502–510.[CrossRef][Medline]
Matsuda
M
&
DeFronzo
RA (1999). Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care
22, 1462–1470.
Naressi A, Couturier C, Devos JM, Janssen M, Mangeat C, de Beer R & Graveron-Demilly D (2001). Java-based graphical user interface for the MRUI quantitation package. MAGMA 12, 141–152.[Medline]
NHMRC (2003). National Health and Medical Research Council, Dietary Guidelines for Australian Adults. http://www.nhmrc.gov.au/publications/synopses/dietsyn.htm
Pacini G & Bergman RN (1986). MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test. Comput Methods Programs Biomed 23, 113–122.[CrossRef][Medline]
Peters
SJ, Harris
RA, Wu
P, Pehleman
TL, Heigenhauser
GJ
&
Spriet
LL (2001). Human skeletal muscle PDH kinase activity and isoform expression during a 3-day high-fat/
low-carbohydrate diet. Am J Physiol Endocrinol Metab
281, E1151–E1158.
Reaven GM (1998). Hypothesis: muscle insulin resistance is the (‘not-so’) thrifty genotype. Diabetologia 41, 482–484.[CrossRef][Medline]
Roden M, Price TB, Perseghin G, Petersen KF, Rothman DL, Cline GW & Shulman GI (1996). Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest 97, 2859–2865.[Medline]
Ruell PA & Gass GC (1991). Enzymatic measurement of 3-hydroxybutyrate in extracts of blood without neutralization. Ann Clin Biochem 28, 183–184.
Saad MF, Anderson RL, Laws A, Watanabe RM, Kades WW, Chen YD, Sands RE, Pei D, Savage PJ & Bergman RN (1994). A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance. Insulin Resistance Atherosclerosis Study. Diabetes 43, 1114–1121.[Abstract]
Schenk
S, Cook
JN, Kaufman
AE
&
Horowitz
JF (2005). Postexercise insulin sensitivity is not impaired after an overnight lipid infusion. Am J Physiol Endocrinol Metab
288, E519–E525.
Schmitz-Peiffer
C, Craig
D
&
Biden
T (1999). Ceramide generation is sufficient to account for the inhibition of the insulin-stimulated PKB pathway in C2C12 skeletal muscle cells pretreated with palmitate. J Biol Chem
274, 24202–24210.
Schwarz JM, Neese RA, Turner S, Dare D & Hellerstein MK (1995). Short-term alterations in carbohydrate energy intake in humans. Striking effects on hepatic glucose production, de novo lipogenesis, lipolysis, and whole-body fuel selection. J Clin Invest 96, 2735–2743.[Medline]
Sparti A & Decombaz J (1992). Effect of diet on glucose tolerance 36 hours after glycogen-depleting exercise. Eur J Clin Nutr 46, 377–385.[Medline]
Stannard SR & Johnson NA (2004). Insulin resistance and elevated triglyceride in muscle: more important for survival than ‘thrifty’ genes? J Physiol 555, 595–607.
Stannard
SR, Thompson
MW, Fairbairn
K, Huard
B, Sachinwalla
T
&
Thompson
CH (2002). Fasting for 72 h increases intramyocellular lipid content in nondiabetic, physically fit men. Am J Physiol Endocrinol Metab
283, E1185–E1191.
Szczepaniak LS, Babcock EE, Schick F, Dobbins RL, Garg A, Burns DK, McGarry JD & Stein DT (1999). Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo. Am J Physiol 276, E977–E989.
Webber J, Taylor J, Greathead H, Dawson J, Buttery PJ & Macdonald IA (1994). Effects of fasting on fatty acid kinetics and on the cardiovascular, thermogenic and metabolic responses to the glucose clamp. Clin Sci 87, 697–706.
|
Acknowledgements |
|---|
Author's present address
N. A. Johnson: School of Exercise and Sports Science, The University of Sydney, Lidcombe 1825, Australia.
This article has been cited by other articles:
|
|
 |
|
  R. W. van der Meer, S. Hammer, H. J. Lamb, M. Frolich, M. Diamant, L. J. Rijzewijk, A. de Roos, J. A. Romijn, and J. W. A. Smit Effects of Short-Term High-Fat, High-Energy Diet on Hepatic and Myocardial Triglyceride Content in Healthy Men J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2702 - 2708. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Hammer, R. W. van der Meer, H. J. Lamb, M. Schar, A. de Roos, J. W. A. Smit, and J. A. Romijn Progressive Caloric Restriction Induces Dose-Dependent Changes in Myocardial Triglyceride Content and Diastolic Function in Healthy Men J. Clin. Endocrinol. Metab., February 1, 2008; 93(2): 497 - 503. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-P. St-Onge, B. R Newcomer, S. Buchthal, I. Aban, D. B Allison, A. Bosarge, and B. Gower Intramyocellular lipid content is lower with a low-fat diet than with high-fat diets, but that may not be relevant for health Am. J. Clinical Nutrition, November 1, 2007; 86(5): 1316 - 1322. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
significantly different LC versus C (P < 0.05).